Literature DB >> 25243526

P311 modulates hepatic stellate cells migration.

Eduardo L Guimarães1, Leslie Stradiot, Inge Mannaerts, Ben Schroyen, Leo A van Grunsven.   

Abstract

BACKGROUND & AIMS: Liver fibrosis is induced by the accumulation of extracellular matrix, deposited mainly by activated hepatic stellate cells (HSCs). One key characteristic of stellate cell activation is the directional migration to the site of injury during the wound-healing process. P311 is a protein that has been shown to play a role in migration and we aimed to study a possible role for this protein during stellate cell migration.
METHODS: Mouse stellate cells were isolated and cultured in vitro to investigate P311 protein and gene expression during HSC activation by immunocytochemistry and RT-qPCR respectively. Expression of P311 during in vivo activation was evaluated in CCl4 and bile duct ligation-induced liver fibrosis. Production of reactive oxygen species was determined using the fluorescent probe DCFH-DA. By siRNA-mediated knockdown of P311, we investigated a possible effect on proliferation by incorporation of EdU and on migration by Boyden chamber assays.
RESULTS: P311 gene expression was increased during both in vitro and in vivo activation of HSCs. siRNA-mediated knockdown led to a decrease in reactive oxygen production and cell proliferation. Migration induced by different chemokines, such as PDGF-bb and MCP-1 was inhibited by knockdown of P311.
CONCLUSIONS: P311 is central to reactive oxygen species-mediated HSC migration induced by different chemokines.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  chemokines; liver fibrosis; migration

Mesh:

Substances:

Year:  2014        PMID: 25243526     DOI: 10.1111/liv.12691

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  7 in total

1.  Widespread Dysregulation of Long Noncoding Genes Associated With Fatty Acid Metabolism, Cell Division, and Immune Response Gene Networks in Xenobiotic-exposed Rat Liver.

Authors:  Kritika Karri; David J Waxman
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

2.  Silibinin Inhibits Proliferation and Migration of Human Hepatic Stellate LX-2 Cells.

Authors:  Devaraj Ezhilarasan; Jonathan Evraerts; Sid Brice; Pedro Buc-Calderon; Sivanesan Karthikeyan; Etienne Sokal; Mustapha Najimi
Journal:  J Clin Exp Hepatol       Date:  2016-01-13

3.  PHP14 regulates hepatic stellate cells migration in liver fibrosis via mediating TGF-β1 signaling to PI3Kγ/AKT/Rac1 pathway.

Authors:  Anjian Xu; Yanmeng Li; Wenshan Zhao; Fei Hou; Xiaojin Li; Lan Sun; Wei Chen; Aiting Yang; Shanna Wu; Bei Zhang; Jingyi Yao; Huan Wang; Jian Huang
Journal:  J Mol Med (Berl)       Date:  2017-11-03       Impact factor: 4.599

4.  P311 promotes renal fibrosis via TGFβ1/Smad signaling.

Authors:  Zhihui Yao; Sisi Yang; Weifeng He; Lian Li; Rui Xu; Xiaorong Zhang; Haisheng Li; Rixing Zhan; Wei Sun; Jianglin Tan; Junyi Zhou; Gaoxing Luo; Jun Wu
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

Review 5.  P311, Friend, or Foe of Tissue Fibrosis?

Authors:  Leslie Stradiot; Inge Mannaerts; Leo A van Grunsven
Journal:  Front Pharmacol       Date:  2018-10-12       Impact factor: 5.810

6.  Molecular Mechanism of Mesenchyme Homeobox 1 in Transforming Growth Factor β1-Induced P311 Gene Transcription in Fibrosis.

Authors:  Zhiyuan Wei; Chao Han; Haisheng Li; Weifeng He; Junyi Zhou; Hui Dong; Yuzhang Wu; Yi Tian; Gaoxing Luo
Journal:  Front Mol Biosci       Date:  2020-04-28

Review 7.  Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents.

Authors:  Cameron M Callaghan; M M Hasibuzzaman; Samuel N Rodman; Jessica E Goetz; Kranti A Mapuskar; Michael S Petronek; Emily J Steinbach; Benjamin J Miller; Casey F Pulliam; Mitchell C Coleman; Varun V Monga; Mohammed M Milhem; Douglas R Spitz; Bryan G Allen
Journal:  Cancers (Basel)       Date:  2020-08-12       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.